Przedsiębiorstwo Wdrożeń Technicznych - Eurocimsp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2004-01-15
Share capital
100,100.00 PLN
Registered address
Zdrojowa 80, 02-927 Warszawa, Poland

Financials

Total Assets
11.46k
-2.0% vs 2024

Revenue history

From the notes

Profit allocationLoss to be covered

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 91 days late).

  • 202515/07/2026
  • 202413/07/2025
  • 202309/07/2024
  • 202207/07/2023
  • 202114/10/2022
  • 202028/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Trademarks

Przedsiębiorstwo Wdrożeń Technicznych - Eurocim holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 1999.

MarkNumberClassesStatusProtected until
eurocim(word)Z.2095519, 42Protected Nov 9, 2029
MarkProtected until
eurocim(word)Nov 9, 2029

Authorized Representatives

Grażyna Teresa Skałowska – President of the Management Board
Olgierd Władysław Skałowski – Attorney-in-fact

Manner of representation

Members of the management board and commercial proxies independently.

Ownership

OwnerSharesShare valueStake
Grażyna Teresa Skałowskaage 70
10$2,703.9410%
Karol Olgierd Skałowski
10$2,703.9410%
Olgierd Władysław Skałowskiage 79
70$18,927.6170%
Piotr Olgierd Skałowskiage 41
10$2,703.9410%

Olgierd Władysław Skałowski, Grażyna Teresa Skałowska, Karol Olgierd Skałowski and Piotr Olgierd Skałowski hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1996-01-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$21
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$21

FAQ

Last updated: 2026-07-17